David Maske

David Maske is the Senior Business Development Manager, Drug Delivery at DSM Biomedical. David joined DSM in 2010 and leads the drug delivery business development activities in the orthopedic, cardiovascular and pain management therapeutic areas. DSM develops and formulates injectable and implantable drug delivery systems, made of bioresorbable polymers, that release precise quantities of therapeutic agents gradually over time. 

David is an experienced business development executive in the life sciences industries with a proven track record establishing successful partnerships, collaborations and joint ventures. Prior to joining DSM, David served as Director of Operations for Ganeden Biotech and was responsible for licensing and managing the Intellectual Property portfolio of the company and numerous research and development projects. David also served as Operations Manager at Athersys, a biopharmaceutical company involved in  the cardiovascular, neurological, inflammatory and immune disease areas. Prior to Athersys, David was with AMRESCO, Inc, a biochemical company, where he managed business development and product development; leading R&D and marketing of products for the pharmaceutical, diagnostic and molecular biology industries.

David received a B.A. and M.A. from Kent State University.